Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The chemokine-mediated metastatic process describes the role of chemokines and their receptors in facilitating cancer cell dissemination and metastasis. It involves multiple steps, including pre-metastatic niche formation, recruitment of immune and stromal cells, induction of EMT, and direct promotion of tumor cell migration and invasion. Several chemokine/receptor pairs, such as CXCL8/CXCR1, CCL2/CCR2, and CXCR4/CXCL12, are implicated in this process, and targeting these pathways is under investigation as an anti-metastatic therapeutic strategy.
Varies depending on the specific chemokine/receptor axis targeted, including receptor blockade, inhibition of downstream signaling pathways (e.g., PI3K/Akt, MAPK), and disruption of immune cell recruitment.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine-Mediated Metastatic Process.